Enterin Inc.   Report issue

For profit Phase 2
Founded: Philadelphia PA United States (2016)

Organization Overview

First Clinical Trial
2017
NCT03047629
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Enterin Inc.